Anne Verena Eberhard

Anne Verena Eberhard

Auto-generated profile, based on publicly available information

Anne Verena Eberhard

Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YWYing Wang
Ying Wang
VNVivek Nanda
Vivek Nanda
DDDaniel Direnzo
Daniel Direnzo
JYJianqin Ye
Jianqin Ye
SXSophia Xiao
Sophia Xiao
NLNicholas Leeper
Nicholas Leeper
Significance: Cardiovascular disease remains the world’s leading killer, despite the widespread use of cholesterol-lowering medicines. Recent studies suggest a portion of this residual risk may result from the clonal expansion of cells within the atherosclerotic plaques of diseased blood vessels. How these cells promote inflammation and whether they can be therapeutically targeted remain unclear. The current study suggests that clonally expanding cells may cause disease by triggering the complement cascade while evading immune surveillance. However, these cells also appear to be susceptible to therapies that reactivate phagocytic clearance pathways, suggesting a potential treatment approach for heart disease similar to current oncology efforts directed against the cancer stem cell.

7 March 2022 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
KJKai-Uwe Jarr
Kai-Uwe Jarr
JYJianqin Ye
Jianqin Ye
YKYoko Kojima
Yoko Kojima
ZYZhongde Ye
Zhongde Ye
HGHua Gao
Hua Gao
NLNicholas Leeper
Nicholas Leeper

7 December 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
AFAlyssa M. Flores
Alyssa M. Flores
ASAlejandro Schuler
Alejandro Schuler
AEAnne Verena Eberhard
Anne Verena Eberhard
JOJeffrey W. Olin
Jeffrey W. Olin
John Patrick CookeJohn Patrick Cooke
John Patrick Cooke
ERElsie G. Ross
Elsie G. Ross
Background: The promise of precision population health includes the ability to use robust patient data to tailor prevention and care to specific groups. Advanced analytics may allow for automated detection of clinically informative subgroups that account for clinical, genetic, and environmental variability. This study sought to evaluate whether unsupervised machine learning approaches could interpret heterogeneous and missing clinical data to discover clinically important coronary artery disease subgroups. Methods and Results: The Genetic Determinants of Peripheral Arterial Disease study is a prospective cohort that includes individuals with newly diagnosed and/or symptomatic coronary artery disease. We applied generalized low rank modeling and K‐means cluster analysis using 155 phenotypic and genetic variables from 1329 participants. Cox proportional hazard models were used to examine associations between clusters and major adverse cardiovascular and cerebrovascular events and all‐cause mortality. We then compared performance of risk stratification based on clusters and the American College of Cardiology/American Heart Association pooled cohort equations. Unsupervised analysis identified 4 phenotypically and prognostically distinct clusters. All‐cause mortality was highest in cluster 1 (oldest/most comorbid; 26%), whereas major adverse cardiovascular and cerebrovascular event rates were highest in cluster 2 (youngest/multiethnic; 41%). Cluster 4 (middle‐aged/healthiest behaviors) experienced more incident major adverse cardiovascular and cerebrovascular events (30%) than cluster 3 (middle‐aged/lowest medication adherence; 23%), despite apparently similar risk factor and lifestyle profiles. In comparison with the pooled cohort equations, cluster membership was more informative for risk assessment of myocardial infarction, stroke, and mortality. Conclusions: Unsupervised clustering identified 4 unique coronary artery disease subgroups with distinct clinical trajectories. Flexible unsupervised machine learning algorithms offer the ability to meaningfully process heterogeneous patient data and provide sharper insights into disease characterization and risk assessment. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00380185.

7 February 2021 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
PTPavlos Tsantilas
Pavlos Tsantilas
SLShen Lao
Shen Lao
ZWZhiyuan Wu
Zhiyuan Wu
AEAnne Eberhard
Anne Eberhard
GWGreg Winski
Greg Winski
NLNicholas Leeper
Nicholas Leeper
Atherosclerotic cerebrovascular disease underlies the majority of ischaemic strokes and is a major cause of death and disability. While plaque burden is a predictor of adverse outcomes, plaque vulnerability is increasingly recognized as a driver of lesion rupture and risk for clinical events. Defining the molecular regulators of carotid instability could inform the development of new biomarkers and/or translational targets for at-risk individuals. Using two independent human endarterectomy biobanks, we found that the understudied glycoprotein, chitinase 3 like 1 (CHI3L1), is up-regulated in patients with carotid disease compared to healthy controls. Further, CHI3L1 levels were found to stratify individuals based on symptomatology and histopathological evidence of an unstable fibrous cap. Gain- and loss-of-function studies in cultured human carotid artery smooth muscle cells (SMCs) showed that CHI3L1 prevents a number of maladaptive changes in that cell type, including phenotype switching towards a synthetic and hyperproliferative state. Using two murine models of carotid remodelling and lesion vulnerability, we found that knockdown of Chil1 resulted in larger neointimal lesions comprised by de-differentiated SMCs that failed to invest within and stabilize the fibrous cap. Exploratory mechanistic studies identified alterations in potential downstream regulatory genes, including large tumour suppressor kinase 2 (LATS2), which mediates macrophage marker and inflammatory cytokine expression on SMCs, and may explain how CHI3L1 modulates cellular plasticity. CHI3L1 is up-regulated in humans with carotid artery disease and appears to be a strong mediator of plaque vulnerability. Mechanistic studies suggest this change may be a context-dependent adaptive response meant to maintain vascular SMCs in a differentiated state and to prevent rupture of the fibrous cap. Part of this effect may be mediated through downstream suppression of LATS2. Future studies should determine how these changes occur at the molecular level, and whether this gene can be targeted as a novel translational therapy for subjects at risk of stroke.

22 October 2020 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
KJKai-Uwe Jarr
Kai-Uwe Jarr
JYJianqin Ye
Jianqin Ye
YKYoko Kojima
Yoko Kojima
VNVivek Nanda
Vivek Nanda
AFAlyssa M. Flores
Alyssa M. Flores
NLNicholas Leeper
Nicholas Leeper
Objective: This study sought to determine whether 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography could be applied to a murine model of advanced atherosclerotic plaque vulnerability to detect response to therapeutic intervention and changes in lesion stability. Approach and Results: To analyze plaques susceptible to rupture, we fed ApoE −/− mice a high-fat diet and induced vulnerable lesions by cast placement over the carotid artery. After 9 weeks of treatment with orthogonal therapeutic agents (including lipid-lowering and proefferocytic therapies), we assessed vascular inflammation and several features of plaque vulnerability by 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography and histopathology, respectively. We observed that 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography had the capacity to resolve histopathologically proven changes in plaque stability after treatment. Moreover, mean target-to-background ratios correlated with multiple characteristics of lesion instability, including the corrected vulnerability index. Conclusions: These results suggest that the application of noninvasive 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography to a murine model can allow for the identification of vulnerable atherosclerotic plaques and their response to therapeutic intervention. This approach may prove useful as a drug discovery and prioritization method.

24 November 2020
Verified
Conference Paper
Closed access
PDF file
APAdalberto Bosco Castro Pereira
Adalberto Bosco Castro Pereira
ISIgor Nascimento Guanais Santos
Igor Nascimento Guanais Santos
LALuan Felipe Cruz Alves
Luan Felipe Cruz Alves
AEAnne Eberhard
Anne Eberhard
This paper deals with initial results by using Augmented Reality and Transversal System of Teaching-Learning (TSTL) to teach anatomy in an undergraduate course of Physical Education. The ongoing project aims to use existing and low-cost resources in lessons to promote accessibility and school inclusion. The resources needed for this research are smartphones in the perspective of BYOD (Bring Your Own Device) and VR cardboards as an optional feature to increase immersion. This research is qualitative, and its methodology is grounded in action-research. Analysis of data collected were based in the theory of Structural Cognitive Modifiability (SCM) of Reuven Feuerstein.